Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
Madeeha Mian, Rachel Dunlap, Eric L. Simpson
Abstract
Atopic dermatitis (AD) is an inflammatory skin condition affecting 3% to 10% of adults and 10% to 20% of children globally.1 Systemic therapies such as cyclosporine, methotrexate, azathioprine, and mycophenolate mofetil have variable levels of efficacy and potential adverse effects.2
Topics & Concepts
MedicineAtopic dermatitisDupilumabAzathioprineDermatologyMethotrexateMycophenolateAdverse effectImmunologyInternal medicineTransplantationDiseaseDermatology and Skin DiseasesFood Allergy and Anaphylaxis ResearchUrticaria and Related Conditions